rawfin.tv
Attovia Therapeutics Raises $289 Million in US IPO
MarketsstocksAI Generated

Attovia Therapeutics Raises $289 Million in US IPO

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases, successfully raised $289 million in its U.S. initial public offering. The Goldman Sachs-backed biotech firm aims to address high unmet medical needs with its pipeline.

Attovia TherapeuticsbiotechIPOhealthcareventure capital

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks